For the Quarter Ending September 2025
APAC
• In China, the Cyanoacetamide Price Index rose by 4.98% quarter-over-quarter, driven by maintenance and logistics disruptions.
• The average Cyanoacetamide price for the quarter was approximately USD 3055/MT, reflecting tightened supply and elevated logistics costs.
• Cyanoacetamide Spot Price strengthened as the Price Index signaled tighter availability amid sustained pharmaceutical sector buying.
• Cyanoacetamide Price Forecast shows modest sequential gains driven by maintenance cycles, inventory drawdowns, and higher transport costs.
• Cyanoacetamide Production Cost Trend reflects higher inland freight, packaging inflation, and extended shipping routes increasing unit costs.
• Cyanoacetamide Demand Outlook remains firm with pharmaceutical forward buying, export restocking, and cautious domestic procurement sustaining prices.
• Inventory drawdowns and robust export enquiries kept the Price Index elevated despite some regional demand softness.
• Scheduled maintenance and weather related shutdowns constrained output, supporting margins and keeping the Price Index on an upward trajectory.
Europe
• In Europe, Cyanoacetamide market trends were mixed through the September quarter, with uneven demand recovery across Western and Central regions.
• The Cyanoacetamide Price Index moved within a narrow band, as weaker industrial activity offset gains from stable pharmaceutical orders.
• Spot market tone remained balanced, with limited arbitrage activity and steady contract fulfillment.
• The Production Cost Trend reflected pressure from high energy tariffs, packaging inflation, and variable shipping rates tied to inland transport constraints.
• Supply chains stabilized after earlier disruptions, though extended lead times and compliance-related delays persisted.
• Demand Outlook showed steady pharmaceutical uptake but cautious procurement from intermediate chemical buyers.
• Inventory positions remained lean, as distributors opted for conservative stock levels amid cost uncertainty.
• Market fundamentals suggested a cautiously stable environment with localized tightness in select grades.
North America
• In North America, Cyanoacetamide market sentiment improved through the quarter, supported by steady downstream pharmaceutical consumption and gradual supply normalization after prior maintenance outages.
• The Cyanoacetamide Price Index exhibited a mild upward trend, reflecting moderate cost pressures from raw materials and freight.
• Spot market activity strengthened as distributors replenished inventories in anticipation of fourth-quarter pharmaceutical demand.
• The Cyanoacetamide Production Cost Trend indicated rising transportation surcharges and elevated energy costs across key manufacturing hubs.
• Supply-side constraints remained contained, but logistical inefficiencies and port congestion limited any substantial price easing.
• Demand Outlook stayed resilient with strong formulation and intermediate segment inquiries, despite muted industrial off-take.
• Margins improved slightly as producers balanced throughput with disciplined output management.
• Forward indicators suggest steady-to-firm conditions through Q4 2025 amid cautious restocking and moderate input cost escalation.
Why did the price of Cyanoacetamide change in September 2025 in APAC?
• Scheduled plant maintenance reduced domestic supply, tightening markets and prompting immediate upward Price Index pressure.
• Typhoon disruptions and port congestion extended inland logistics, raising costs and delaying shipments, supporting higher prices.
• Forward buying ahead of tariff uncertainty and export demand drew inventories down, sustaining the Cyanoacetamide Price Index.
For the Quarter Ending June 2025
APAC
• Price Index Trends (April–June 2025): The Cyanoacetamide Price Index rose from USD 2,870/MT in April to 2,900/MT in May, and further to 2,960/MT in June (FOB Shanghai). The trend reflects a steady upward shift in spot pricing during this period.
• Cyanoacetamide Spot Price & Supply Dynamics: The increasing Cyanoacetamide Spot Price was supported by tighter raw material availability and improving demand in pharmaceuticals and specialty chemical intermediates. Export activity from China remained firm, resulting in limited domestic inventory cushion—forcing spot premiums upward.
• Cyanoacetamide Production Cost Trend: Production cost pressures increased gradually due to feedstock chain tightness and incremental energy cost increases. The rising cost basis contributed to upward price momentum in May–June, even with no sudden spikes in raw material cost.
• Cyanoacetamide Demand Outlook: Demand remained strong from pharmaceutical intermediates, agrochemical applications, and specialty materials manufacturing, particularly in North Asia (including China). Growing consumption in API and crop protection synthesis supported robust offtake.
• Why did the price change in July 2025?
The Price Index is expected to increase modestly in July 2025, driven by ongoing healthy demand from pharma and agrochemical sectors and constrained supply. Unless raw material supply loosens or export flows slow, the upward momentum is likely to persist.
Europe
• Price Index Trends (April–June 2025): The Cyanoacetamide Price Index in Europe fluctuated modestly, influenced by variations in API production cycles, supply availability, and Chinese export activity.
• Cyanoacetamide Spot Price & Supply Dynamics: European spot prices followed import parity with China, with additional freight and regulatory costs affecting landed pricing. Supply intermittency from Asia impacted offer levels regionally.
• Cyanoacetamide Production Cost Trend: Cost structures were shaped by regional precursor availability and environmental compliance costs. No major raw material shocks, but cost bases remained firm.
• Cyanoacetamide Demand Outlook: Demand derived from pharmaceutical R&D, contract manufacturing, agrochemicals, and performance materials. Growth was steady but regionally varied depending on pipeline activity.
• Why did the price change in July 2025?
The Price Index is likely to edge higher in July 2025, assuming import prices remain elevated and downstream demand from European pharma and agrochemical firms stays consistent.
North America
• Price Index Trends (April–June 2025): Prices manifested moderate volatility, tracking import-linked parity with Chinese FOB rates and variances in U.S./Canadian feedstock costs.
• Cyanoacetamide Spot Price & Supply Dynamics: Spot prices were largely aligned with import parity pricing. Supply chains from Asia, lead times, and domestic contract allocations influenced availability.
• Cyanoacetamide Production Cost Trend: Costs remained consistent, comparatively tied to global feedstock dynamics and stable energy costs. No sudden feedstock disruptions were reported.
• Cyanoacetamide Demand Outlook: Demand was driven by pharmaceutical production, agrochemical synthesis, and industrial specialty chemicals; growth was in line with U.S./Canada health and agriculture markets.
• Why did the price change in July 2025?
The Price Index is expected to rise slightly, assuming continued demand from pharma and agrochemical segments and steady import-linked supply conditions without major relief.
